Ruffer LLP’s Sabra Healthcare REIT SBRA Stock Holding History

Ruffer LLP’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,094	Closed	-$438K	–	229
2025 Q4	$438K	Buy	23,094 +4,208	+22%	+$78K	0.02%	145
2025 Q3	$352K	Buy	+18,886	New	+$353K	0.02%	99

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Ruffer LLP's SBRA Position: Q1 2026 in Review

Ruffer LLP sold out of Sabra Healthcare REIT (SBRA) in Q1 2026, closing a stake of 23,094 shares — an estimated $438K sold.

Ruffer LLP first reported a position in SBRA in Q3 2025 and held it in 2 quarters. The position peaked at $438K in Q4 2025. 462 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

Ruffer LLP reported no remaining Sabra Healthcare REIT position as of Q1 2026 after selling out during the quarter.
Ruffer LLP sold 23,094 Sabra Healthcare REIT shares in Q1 2026, an estimated $438K.
Ruffer LLP first reported a position in Sabra Healthcare REIT in Q3 2025 and held it in 2 quarters.
Ruffer LLP's Sabra Healthcare REIT position peaked at $438K in Q4 2025.
462 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Ruffer LLP's 13F filing for Q1 2026, filed 13 May 2026.